Levodopa/Benserazid Neuraxpharm (Benserazide Hydrochloride, Levodopa)

Levodopa/Benserazide is used in the management of Parkinsonian disorders by restoring dopaminergic activity.

• Parkinson's disease: improves motor function and reduces rigidity and bradykinesia.
• Parkinsonian syndrome: alleviates tremor, stiffness and gait disturbances.
• Levodopa‑responsive Parkinsonism: provides symptomatic relief when dopamine deficiency is the primary cause.

• Levodopa crosses the blood‑brain barrier and is decarboxylated to dopamine, replenishing central dopaminergic tone. Benserazide, a peripheral aromatic L‑amino acid decarboxylase inhibitor, blocks the conversion of levodopa outside the CNS, increasing the amount of levodopa that reaches the brain and reducing peripheral side effects.

Levodopa/Benserazide may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Orthostatic hypotension: dizziness upon standing.
• Headache: transient cranial discomfort.
• Insomnia: difficulty initiating or maintaining sleep.
• Dyspepsia: indigestion or abdominal discomfort.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Dyskinesia: involuntary, erratic movements.
• Psychiatric disturbances: hallucinations, confusion or depression.
• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Cardiac arrhythmias: irregular heart rhythms, especially in patients with pre‑existing cardiac disease.
• Neuroleptic malignant‑like syndrome: rare but life‑threatening reaction with fever and muscle rigidity.

Before initiating therapy, clinicians should consider several safety aspects.

• Blood pressure monitoring: watch for orthostatic drops, especially in the elderly.
• Psychiatric assessment: evaluate history of psychosis or depression.
• Renal function: adjust dose in patients with severe impairment.
• Abrupt discontinuation: avoid sudden stop to prevent withdrawal syndrome.
• Concomitant dopamine antagonists: use with caution as they may reduce efficacy.
• Store at room temperature: keep in the original container, protect from moisture and light.

Levodopa/Benserazide can interact with several drug classes.

Major Interactions (Avoid)

• Non‑selective MAO inhibitors: risk of hypertensive crisis.
• Antipsychotics (dopamine blockers): may diminish therapeutic effect.
• High‑protein meals: can impair levodopa absorption.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: additive blood‑pressure lowering.
• SSRIs and SNRIs: potential for serotonin syndrome.
• Iron or vitamin B6 supplements: may reduce levodopa bioavailability.
• Diuretics: may affect electrolyte balance and blood pressure.